AGP Franklin LLC Has $2.02 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

AGP Franklin LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 36.5% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,857 shares of the healthcare conglomerate’s stock after selling 2,215 shares during the period. AGP Franklin LLC’s holdings in UnitedHealth Group were worth $2,020,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AWM Capital LLC increased its stake in shares of UnitedHealth Group by 24.9% in the first quarter. AWM Capital LLC now owns 561 shares of the healthcare conglomerate’s stock valued at $294,000 after buying an additional 112 shares during the period. Brio Consultants LLC increased its holdings in UnitedHealth Group by 75.9% in the first quarter. Brio Consultants LLC now owns 751 shares of the healthcare conglomerate’s stock worth $393,000 after purchasing an additional 324 shares in the last quarter. University of Texas Texas AM Investment Management Co. increased its holdings in UnitedHealth Group by 757.0% in the first quarter. University of Texas Texas AM Investment Management Co. now owns 857 shares of the healthcare conglomerate’s stock worth $449,000 after purchasing an additional 757 shares in the last quarter. Richards Merrill & Peterson Inc. increased its holdings in UnitedHealth Group by 1.7% in the first quarter. Richards Merrill & Peterson Inc. now owns 1,979 shares of the healthcare conglomerate’s stock worth $1,037,000 after purchasing an additional 34 shares in the last quarter. Finally, Metis Global Partners LLC increased its holdings in UnitedHealth Group by 10.4% in the first quarter. Metis Global Partners LLC now owns 58,738 shares of the healthcare conglomerate’s stock worth $30,764,000 after purchasing an additional 5,535 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer owned 203,796 shares of the company’s stock, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 in the last 90 days. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $280.69 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The business has a fifty day simple moving average of $301.58 and a two-hundred day simple moving average of $424.22. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a market capitalization of $254.62 billion, a P/E ratio of 11.75, a P/E/G ratio of 1.39 and a beta of 0.45.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.15%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on UNH shares. Robert W. Baird downgraded UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price for the company. in a report on Wednesday, June 11th. Barclays reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Mizuho cut their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. Finally, Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $392.29.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.